Latest Manufacturing News

Marquee Resources (ASX:MQR) has secured a non-exclusive R&D patent licence with Oak Ridge National Laboratory, granting access to NEAREST technology tailored for clay-rich rare earth deposits like Redlings in WA. This partnership could reshape processing efficiency and environmental impact for Marquee’s significant inferred resource.

ReNerve has moved its NervAlign Nerve Guide Matrix into stage 3 of commercial development, a key step toward FDA submission and eventual market entry. This progress supports the company’s ambition to provide surgeons with an alternative to donor nerves for repairing severe peripheral nerve injuries.

Mesoblast has acquired exclusive rights to a patented chimeric antigen receptor platform designed to enhance the targeting and potency of its mesenchymal stromal cell therapies, aiming to expand treatment options for inflammatory and autoimmune diseases.

Nufarm reports a robust first half of FY26 with underlying EBITDA rising 17% and net debt falling by $130 million, while new CEO Rico Christensen initiates a $50 million cost savings program as part of a strategic refresh.

Genetic Signatures has locked in a 10-year supply deal with Denmark’s Hvidovre Hospital for its EasyScreen™ Pan-Enteric assay, marking a significant step in its European expansion. The agreement covers 28,000 tests in the first year with growth expected, leveraging the company’s proprietary 3base® technology to streamline complex gastrointestinal pathogen detection.

Nufarm posted a 17% rise in underlying EBITDA for 1H FY26 and unveiled a fresh $50 million cost saving initiative under new CEO Rico Christensen, aiming to sharpen earnings quality and accelerate debt reduction.

Critical Resources has defined a focused 2026 exploration program at its Mavis Lake lithium project while confirming an orogenic gold system in New Zealand and delivering promising early results from its solid-state lithium-ion battery evaluation.

Forrestania Resources has revealed further high-grade niobium mineralisation from its maiden RC drilling at the Wozi Project, Malawi, validating a large near-surface system with grades up to 0.94% Nb2O5 and confirming the project's critical minerals potential.

Zoono Group has boosted its cash receipts by NZ$333,000 this quarter, driven by initial orders worth NZ$585,000 in its fresh food shelf-life extension sector. Despite operating losses, the company expects to sustain operations through signed contracts and inventory.

Janus Electric has locked in two California HVIP vouchers worth US$112,500 each for its initial US vehicle conversions, validating its tech under a key decarbonisation program. It also inked a non-binding MOU with Energy One to explore battery swap and charging infrastructure for Class 8 freight trucks across North America.

Clarity Pharmaceuticals has secured a major manufacturing deal with Nucleus RadioPharma to produce its next-generation prostate cancer imaging agent, 64Cu-SAR-bisPSMA, ramping up supply ahead of anticipated US market entry.

Black Canyon has kicked off a substantial 15,000m RC drilling campaign at its Wandanya Project, aiming to define and grow its high-grade manganese and iron resource with first assays due in May 2026.